NURIX THERAPEUTICS ANNOUNCES FIRST PATIENT ENROLLED IN PHASE 1B/2 COMBINATION STUDY OF BEXOBRUTIDEG IN CHRONIC LYMPHOCYTIC LEUKEMIA

Reuters · 2d ago

Please log in to view news